Kennedy University Hospital INC.

Kennedy University Hospital INC. was paid $209.41M by Medicaid between Jan 2018 and Dec 2024, across 520 billing codes. Its largest line is 99284, emergency room visit (serious) — 32% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	544,831	$35.79M
2019	516,083	$33.69M
2020	426,700	$25.64M
2021	528,397	$29.65M
2022	675,962	$30.69M
2023	693,785	$30.45M
2024incomplete	483,454	$23.49M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	32%	123,887	108,634	$67.54M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	19%	101,503	92,901	$39.21M
G0378	Hospital observation service, per hour	4.7%	33,804	18,624	$9.94M
99282	Emergency department visit for the evaluation and management, low to moderate severity	4.7%	47,839	44,312	$9.80M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	4.2%	26,441	23,835	$8.74M
OP370		1.6%	18,838	17,494	$3.34M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	1.4%	2,624	2,532	$3.02M
96375	Therapeutic injection; each additional sequential IV push	<1%	59,060	45,418	$1.94M
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	21,962	20,646	$1.90M
70450	Computed tomography, head or brain; without contrast material	<1%	26,809	24,711	$1.71M
90853	Group psychotherapy (other than of a multiple-family group)	<1%	22,721	6,370	$1.57M
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	943	918	$1.56M

508 more codes

96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	68,101	$1.54M
H0035	Mental health partial hospitalization, treatment, less than 24 hours	<1%	7,208	$1.50M
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	37,072	$1.28M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	40,807	$1.27M
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	7,082	$1.26M
OP270		<1%	54,694	$1.17M
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	2,493	$1.14M
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	859	$1.02M
93975		<1%	7,808	$999K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	22,226	$983K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	1,134	$974K
OP710		<1%	14,416	$968K
71046	Radiologic examination, chest; 2 views	<1%	39,776	$953K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	7,460	$911K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	1,813	$877K
41899	Unlisted procedure, dentoalveolar structures	<1%	532	$820K
59025	Fetal non-stress test	<1%	3,745	$804K
76830	Ultrasound, transvaginal	<1%	8,959	$795K
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	<1%	14,856	$794K
76801		<1%	6,700	$780K
80048	Basic metabolic panel (calcium, ionized)	<1%	182,326	$767K
96361	Intravenous infusion, hydration; each additional hour	<1%	46,335	$764K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	25,470	$716K
72125	Computed tomography, cervical spine; without contrast material	<1%	10,398	$708K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	86,977	$703K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	177,633	$685K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	5,640	$642K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	8,875	$638K
71275	Computed tomographic angiography, chest, with contrast material	<1%	7,549	$629K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	2,978	$596K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	4,120	$576K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	11,221	$569K
96376		<1%	24,674	$558K
OP250		<1%	127,202	$532K
62323		<1%	308	$511K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	4,016	$504K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	514	$494K
71045	Radiologic examination, chest; single view	<1%	38,149	$488K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	4,703	$487K
70498		<1%	4,342	$484K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	2,583	$470K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	16,390	$468K
71250		<1%	3,852	$468K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	1,693	$467K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	13,256	$466K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	12,297	$460K
73630		<1%	11,349	$455K
93970		<1%	6,322	$450K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	4,434	$450K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	1,786	$440K
70496		<1%	4,371	$418K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	8,946	$416K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	19,400	$408K
95811		<1%	265	$400K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	28,436	$399K
93971		<1%	4,958	$398K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	4,102	$396K
64493		<1%	231	$381K
64483		<1%	209	$372K
95806		<1%	1,299	$365K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	8,029	$355K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	33,332	$349K
70486		<1%	3,235	$333K
76770		<1%	3,813	$314K
73130		<1%	8,764	$314K
OP272		<1%	7,537	$310K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	14,390	$303K
90791	Psychiatric diagnostic evaluation	<1%	4,391	$295K
76642		<1%	2,613	$275K
77066	Tomosynthesis, mammo	<1%	1,656	$267K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	6,438	$266K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	10,741	$265K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	1,883	$264K
80076		<1%	80,896	$263K
84484		<1%	60,112	$258K
73610		<1%	7,821	$258K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	8,146	$257K
80329		<1%	13,189	$245K
76813		<1%	1,919	$239K
64635		<1%	122	$229K
77063	Screening digital breast tomosynthesis, bilateral	<1%	5,959	$225K
27096		<1%	111	$218K
47562		<1%	160	$214K
73564		<1%	8,468	$201K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	3,316	$200K
72141		<1%	863	$198K
76536		<1%	1,751	$198K
72110		<1%	2,262	$182K
83735		<1%	70,103	$180K
78815	Positron emission tomography (PET) for limited area imaging	<1%	163	$180K
97597		<1%	1,557	$179K
94799		<1%	2,278	$176K
80320		<1%	18,042	$172K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	11,357	$164K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	580	$164K
70491		<1%	1,357	$162K
84443	Thyroid stimulating hormone (TSH)	<1%	13,090	$161K
73030		<1%	7,116	$151K
85610		<1%	51,285	$147K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	11,357	$145K
83880		<1%	15,848	$142K
OP258		<1%	66,340	$138K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	442	$134K
83690		<1%	58,242	$131K
OP229		<1%	2,466	$125K
94761		<1%	8,466	$123K
80053	Comprehensive metabolic panel	<1%	10,955	$120K
73502		<1%	3,724	$117K
85730		<1%	40,107	$116K
J9271	Injection, pembrolizumab, 1 mg	<1%	20	$116K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	321	$113K
82550		<1%	29,250	$113K
74022		<1%	4,627	$112K
82977		<1%	19,589	$111K
82948		<1%	29,700	$108K
97162		<1%	4,234	$106K
74240		<1%	893	$105K
J1756	Injection, iron sucrose, 1 mg	<1%	1,672	$104K
97161		<1%	4,301	$103K
90834	Psychotherapy session, about 45 minutes	<1%	1,019	$102K
72100		<1%	5,311	$101K
A9270	Non-covered item or service	<1%	344,361	$99K
88342		<1%	4,733	$97K
73110		<1%	5,029	$95K
72050		<1%	1,271	$92K
77065	Tomosynthesis, mammo	<1%	1,161	$91K
76870		<1%	1,606	$89K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	425	$88K
87086	Culture, bacterial; quantitative colony count, urine	<1%	25,016	$87K
86900		<1%	12,246	$84K
87040		<1%	16,907	$84K
36415	Collection of venous blood by venipuncture	<1%	33,964	$83K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	4,986	$82K
87507		<1%	743	$77K
86850		<1%	8,646	$76K
J3490	Unclassified drugs	<1%	46,676	$75K
C1889	Implantable/insertable device, not otherwise classified	<1%	388	$74K
81001		<1%	52,279	$74K
J1439	Injection, ferric carboxymaltose, 1 mg	<1%	108	$72K
81003		<1%	34,367	$72K
96367		<1%	3,552	$71K
83605		<1%	15,108	$69K
88341		<1%	1,221	$65K
73590		<1%	4,022	$64K
83970		<1%	713	$63K
81025		<1%	22,550	$61K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	1,382	$60K
80061	Lipid panel	<1%	6,484	$59K
74174		<1%	916	$58K
74018		<1%	2,606	$58K
G0330	Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room	<1%	25	$58K
72131		<1%	861	$57K
96417		<1%	409	$57K
76882		<1%	742	$55K
73080		<1%	2,972	$55K
99214	Doctor's office visit, returning patient (more involved)	<1%	2,752	$54K
73090		<1%	2,991	$54K
85027		<1%	15,702	$54K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	15,486	$54K
12001		<1%	1,264	$53K
84100		<1%	17,026	$53K
A9585	Injection, gadobutrol, 0.1 ml	<1%	3,055	$51K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	745	$50K
86901		<1%	12,338	$49K
93017		<1%	500	$49K
C1769	Guide wire	<1%	1,125	$48K
72040		<1%	1,931	$48K
72070		<1%	1,386	$48K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	1,177	$48K
84702		<1%	10,367	$45K
76376		<1%	1,641	$44K
90715		<1%	5,225	$43K
80365		<1%	2,306	$41K
29125		<1%	1,373	$40K
29515		<1%	1,403	$40K
80349		<1%	995	$39K
87641		<1%	1,311	$39K
87186		<1%	6,608	$38K
83036	Hemoglobin; glycosylated (A1C)	<1%	7,507	$37K
93041		<1%	2,582	$36K
73552		<1%	2,163	$33K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	5,106	$33K
88304		<1%	1,763	$33K
87070		<1%	7,079	$32K
87400		<1%	7,827	$32K
82553		<1%	4,813	$32K
73060		<1%	1,921	$31K
J2060	Injection, lorazepam, 2 mg	<1%	10,371	$30K
73562		<1%	1,013	$30K
T1015	A visit at a community health center or clinic (one all-in rate)	<1%	1,778	$30K
10060		<1%	425	$28K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	19,204	$28K
97113		<1%	765	$27K
95819		<1%	221	$27K
97116		<1%	4,524	$27K
82728		<1%	2,350	$26K
J1815	Injection, insulin, per 5 units	<1%	11,325	$26K
29505		<1%	327	$25K
72170		<1%	1,069	$25K
C1781	Mesh (implantable)	<1%	68	$25K
OP278		<1%	43	$25K
86803		<1%	1,255	$24K
87081		<1%	9,465	$24K
82962		<1%	2,488	$23K
36410		<1%	504	$23K
82607		<1%	2,525	$23K
C2617	Stent, non-coronary, temporary, without delivery system	<1%	336	$22K
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	3,681	$22K
70371		<1%	287	$22K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	976	$22K
82803		<1%	3,130	$21K
80164		<1%	2,350	$21K
77334		<1%	52	$21K
97165		<1%	1,426	$21K
87077		<1%	5,489	$21K
G0283	Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care	<1%	1,041	$20K
74183		<1%	43	$20K
86140		<1%	10,264	$20K
97803		<1%	325	$20K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	7,907	$20K
74230		<1%	442	$20K
83550		<1%	2,608	$19K
97802		<1%	195	$19K
85379		<1%	9,996	$19K
12011		<1%	490	$19K
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	478	$18K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	6,688	$18K
77336		<1%	202	$18K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	29,167	$18K
J2704	Injection, propofol, 10 mg	<1%	14,920	$17K
70544		<1%	113	$17K
71101		<1%	837	$17K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	34,733	$17K
12002		<1%	324	$17K
84145		<1%	2,375	$17K
87340		<1%	914	$16K
71271		<1%	236	$16K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	5,730	$16K
84439		<1%	2,102	$16K
J0690	Injection, cefazolin sodium, 500 mg	<1%	7,147	$16K
92611		<1%	302	$15K
01999		<1%	178	$14K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	15,190	$14K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	12,328	$14K
87147		<1%	3,112	$14K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	10,726	$13K
82150		<1%	1,370	$13K
82746		<1%	1,636	$13K
77085		<1%	408	$13K
90847	Family psychotherapy with the patient present, 50 minutes	<1%	239	$13K
97166		<1%	1,407	$13K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	4,043	$13K
87205		<1%	3,832	$13K
92523		<1%	103	$13K
84132		<1%	1,270	$12K
99152		<1%	421	$12K
86618		<1%	892	$12K
85007		<1%	1,852	$12K
78264		<1%	68	$12K
84703		<1%	1,119	$12K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	513	$12K
G0257	Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility	<1%	439	$11K
87075		<1%	2,152	$11K
84520		<1%	879	$11K
73560		<1%	427	$11K
99213	Doctor's office visit, returning patient (routine)	<1%	865	$11K
83615		<1%	1,933	$11K
51701		<1%	248	$11K
97164		<1%	751	$11K
76000		<1%	893	$11K
82570		<1%	3,790	$11K
99070		<1%	529	$11K
OP637		<1%	2,919	$10K
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	527	$10K
88313		<1%	1,076	$9K
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	526	$9K
J1644	Injection, heparin sodium, per 1000 units	<1%	7,374	$9K
77080		<1%	119	$9K
J3370	Injection, vancomycin hcl, 500 mg	<1%	2,382	$9K
90675		<1%	89	$9K
82310		<1%	992	$9K
96368		<1%	1,132	$9K
94642		<1%	347	$9K
80178		<1%	752	$9K
88307		<1%	486	$8K
80348		<1%	186	$8K
J1630	Injection, haloperidol, up to 5 mg	<1%	5,526	$8K
31720		<1%	31	$8K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	3,195	$7K
85018		<1%	1,661	$7K
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	16,359	$7K
70487		<1%	85	$7K
86780		<1%	728	$7K
84550		<1%	1,931	$7K
73221		<1%	13	$7K
82140		<1%	1,022	$6K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	3,238	$6K
97535	Self-care/home management training, each 15 minutes	<1%	1,175	$6K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	13	$6K
73501		<1%	201	$6K
82784		<1%	140	$6K
78582		<1%	111	$6K
36600		<1%	45	$6K
36430		<1%	544	$6K
88300		<1%	474	$6K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	13,287	$5K
J3535	Drug administered through a metered dose inhaler	<1%	290	$5K
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	228	$5K
84075		<1%	641	$5K
J1170	Injection, hydromorphone, up to 4 mg	<1%	7,614	$5K
84295		<1%	640	$5K
0012A		<1%	187	$5K
J1453	Injection, fosaprepitant, 1 mg	<1%	59	$5K
G1004	Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program	<1%	7,084	$5K
0011A		<1%	211	$5K
78580		<1%	121	$5K
93880		<1%	39	$5K
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	1,542	$5K
84460		<1%	806	$5K
84450		<1%	793	$5K
72220		<1%	239	$5K
95816		<1%	25	$5K
82374		<1%	644	$5K
82435		<1%	643	$5K
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	6,807	$5K
80074		<1%	176	$4K
C9113	Injection, pantoprazole sodium, per vial	<1%	2,915	$4K
74247		<1%	29	$4K
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	503	$4K
92610		<1%	292	$4K
C1773	Retrieval device, insertable (used to retrieve fractured medical devices)	<1%	316	$4K
86920		<1%	123	$4K
M0222	Intravenous injection, bebtelovimab, includes injection and post administration monitoring	<1%	62	$4K
80165		<1%	1,710	$4K
72114		<1%	62	$4K
88312		<1%	360	$4K
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	<1%	80	$4K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	9,992	$4K
87150		<1%	186	$4K
82040		<1%	768	$3K
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	1,190	$3K
83721		<1%	209	$3K
0064A		<1%	95	$3K
84478		<1%	210	$3K
G0433	Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening	<1%	281	$3K
J7030	Infusion, normal saline solution , 1000 cc	<1%	31,444	$3K
86706		<1%	240	$3K
74420		<1%	73	$3K
J3480	Injection, potassium chloride, per 2 meq	<1%	2,140	$3K
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	5,622	$3K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	2,267	$3K
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	1,535	$3K
86787		<1%	191	$3K
J1953	Injection, levetiracetam, 10 mg	<1%	978	$3K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	112	$3K
80362		<1%	61	$3K
96415		<1%	32	$3K
J3411	Injection, thiamine hcl, 100 mg	<1%	1,393	$3K
76820		<1%	46	$3K
94760		<1%	1,811	$3K
A9540	Technetium tc-99m macroaggregated albumin, diagnostic, per study dose, up to 10 millicuries	<1%	221	$2K
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	48	$2K
73521		<1%	54	$2K
72146		<1%	12	$2K
94060		<1%	14	$2K
82247		<1%	326	$2K
93923		<1%	24	$2K
72158		<1%	14	$2K
80358		<1%	133	$2K
76641		<1%	31	$2K
72200		<1%	134	$2K
82947		<1%	475	$2K
86923		<1%	399	$2K
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	1,277	$2K
73700		<1%	25	$2K
29130		<1%	76	$2K
94660		<1%	150	$2K
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	<1%	3,842	$2K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	92	$2K
J7999	Compounded drug, not otherwise classified	<1%	3,650	$2K
J7050	Infusion, normal saline solution, 250 cc	<1%	2,392	$2K
73620		<1%	52	$2K
99153	Mod sedat endo service >5yrs	<1%	75	$2K
J0689	Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg	<1%	1,562	$2K
C2625	Stent, non-coronary, temporary, with delivery system	<1%	14	$2K
C1758	Catheter, ureteral	<1%	13	$1K
85046		<1%	259	$1K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	131	$1K
85014		<1%	42	$1K
87088		<1%	389	$1K
84156		<1%	487	$1K
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	<1%	121	$1K
87449		<1%	52	$1K
86592		<1%	486	$1K
G0297	Low dose ct scan (ldct) for lung cancer screening	<1%	14	$1K
94770		<1%	81	$1K
82465		<1%	208	$1K
77061		<1%	112	$1K
96523		<1%	57	$1K
10061		<1%	24	$1K
S2900	Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure)	<1%	13	$1K
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	1,720	$1K
82010		<1%	308	$1K
86738		<1%	16	$1K
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	992	$1K
85384		<1%	87	$1K
87420		<1%	277	$1K
J2310	Injection, naloxone hydrochloride, per 1 mg	<1%	231	$997.57
J1940	Injection, furosemide, up to 20 mg	<1%	911	$986.36
70360		<1%	62	$949.57
86308		<1%	742	$921.81
J1596	Injection, glycopyrrolate, 0.1 mg	<1%	570	$918.13
87536		<1%	38	$911.66
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	710	$895.37
J7120	Ringers lactate infusion, up to 1000 cc	<1%	9,351	$889.21
93356		<1%	30	$858.49
73000		<1%	28	$832.95
82248		<1%	265	$827.27
J9267	Injection, paclitaxel, 1 mg	<1%	55	$809.10
J1040	Injection, methylprednisolone acetate, 80 mg	<1%	27	$764.18
86038		<1%	133	$733.01
87493		<1%	99	$731.22
88311		<1%	214	$717.09
OP271		<1%	108	$667.35
85651		<1%	345	$647.85
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	196	$605.62
A9558	Xenon xe-133 gas, diagnostic, per 10 millicuries	<1%	94	$599.74
94729		<1%	19	$555.29
90792	Psychiatric diagnostic evaluation with medical services	<1%	13	$541.05
J3250	Injection, trimethobenzamide hcl, up to 200 mg	<1%	53	$521.17
G8989	Self care functional limitation, discharge status, at discharge from therapy or to end reporting	<1%	13	$502.17
G8988	Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	57	$502.17
G8987	Self care functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	57	$502.17
G8980	Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting	<1%	73	$502.17
94727		<1%	19	$452.94
70250		<1%	16	$441.09
J3230	Injection, chlorpromazine hcl, up to 50 mg	<1%	18	$435.40
J8499	Prescription drug, oral, non chemotherapeutic, nos	<1%	1,001	$433.72
J1245	Injection, dipyridamole, per 10 mg	<1%	58	$421.88
J2785	Injection, regadenoson, 0.1 mg	<1%	12	$417.15
0031A		<1%	16	$408.63
90682		<1%	19	$403.68
90686		<1%	98	$403.07
73100		<1%	17	$385.70
86762		<1%	41	$381.40
J0780	Injection, prochlorperazine, up to 10 mg	<1%	537	$378.58
97163		<1%	19	$376.54
73120		<1%	13	$375.29
86318		<1%	141	$369.78
84315		<1%	124	$346.72
29540		<1%	44	$346.31
74020		<1%	19	$345.70
86666		<1%	28	$343.18
86757		<1%	26	$296.64
29105		<1%	12	$290.92
J2470	Injection, pantoprazole sodium, 40 mg	<1%	266	$273.84
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	1,474	$254.21
86753		<1%	30	$244.69
88302		<1%	25	$235.49
J7510	Prednisolone oral, per 5 mg	<1%	418	$223.20
88112		<1%	12	$213.11
88142		<1%	13	$211.10
29530		<1%	17	$204.45
80156		<1%	12	$204.16
99204	Doctor's office visit, new patient (more involved)	<1%	25	$200.57
82043		<1%	77	$182.97
J0736	Injection, clindamycin phosphate, 300 mg	<1%	82	$181.01
90732		<1%	21	$178.48
76080		<1%	13	$173.29
C1729	Catheter, drainage	<1%	55	$164.34
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	30	$161.42
86665		<1%	14	$158.40
J2003	Injection, lidocaine hydrochloride, 1 mg	<1%	371	$152.30
Q9965	Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml	<1%	387	$118.70
73140		<1%	26	$111.67
84436		<1%	27	$109.50
83020		<1%	15	$105.00
82330		<1%	27	$95.18
86701		<1%	12	$89.25
J1836	Injection, metronidazole, 10 mg	<1%	171	$82.38
84480		<1%	14	$78.75
86664		<1%	14	$66.80
82365		<1%	86	$64.14
90662		<1%	16	$62.58
82565		<1%	15	$51.75
J1171	Injection, hydromorphone, 0.1 mg	<1%	198	$44.95
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	224	$39.25
J2550	Injection, promethazine hcl, up to 50 mg	<1%	186	$30.27
85652		<1%	36	$25.05
J2004	Injection, lidocaine hcl with epinephrine, 1 mg	<1%	63	$18.27
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	23	$15.31
Q0222	Injection, bebtelovimab, 175 mg	<1%	62	$11.00
J1580	Injection, garamycin, gentamicin, up to 80 mg	<1%	14	$9.91
89050		<1%	29	$5.80
J2274	Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg	<1%	150	$4.42
G0008	Administration of influenza virus vaccine	<1%	190	$2.62
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	753	$2.00
Q0244	Injection, casirivimab and imdevimab, 1200 mg	<1%	105	$1.00
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	15	$1.00
91301		<1%	455	$0.01
A4216	Sterile water, saline and/or dextrose, diluent/flush, 10 ml	0%	80	$0.00
Q9969	Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose	0%	35	$0.00
90656		0%	21	$0.00
OP324		0%	19	$0.00
91303		0%	15	$0.00
91306		0%	90	$0.00
64484		0%	18	$0.00
91305		0%	18	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMACCRACKEN, TIMOTHY (REGIONAL CFO)